PR Newswire

– 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon, for endovascular

– Sharakah, a closed joint stock company incorporated by Royal Decree No. (76/98), has come on board with Beehive, a leading fintech company, as a new investor. Sharakah contributes to SME development in Oman and provides finance to support Oman’s vision

Latest News